TY - JOUR
T1 - Acidic pH increases airway surface liquid viscosity in cystic fibrosis
AU - Tang, Xiao Xiao
AU - Ostedgaard, Lynda S.
AU - Hoegger, Mark J.
AU - Moninger, Thomas O.
AU - Karp, Philip H.
AU - McMenimen, James D.
AU - Choudhury, Biswa
AU - Varki, Ajit
AU - Stoltz, David A.
AU - Welsh, Michael J.
N1 - Funding Information:
This work was funded by the NIH (HL091842, HL51670, HL11744, by R01GM32373 to A. Varki), by the Research Resource for Biomedical Glycomics (NIH P41GM10349010 to Parastoo Azadi at the Complex Carbohydrate Research Center), by the Cystic Fibrosis Foundation (Research Development Program, OSTEDG1410, STOLTZ14XX0), and by the Roy J. Carver Charitable Trust. D.A. Stoltz was funded by the Gilead Sciences Research Scholars Program in Cystic Fibrosis. M.J. Welsh is an investigator of the Howard Hughes Medical Institute.
PY - 2016/3/1
Y1 - 2016/3/1
N2 - Cystic fibrosis (CF) disrupts respiratory host defenses, allowing bacterial infection, inflammation, and mucus accumulation to progressively destroy the lungs. Our previous studies revealed that mucus with abnormal behavior impaired mucociliary transport in newborn CF piglets prior to the onset of secondary manifestations. To further investigate mucus abnormalities, here we studied airway surface liquid (ASL) collected from newborn piglets and ASL on cultured airway epithelia. Fluorescence recovery after photobleaching revealed that the viscosity of CF ASL was increased relative to that of non-CF ASL. CF ASL had a reduced pH, which was necessary and sufficient for genotype-dependent viscosity differences. The increased viscosity of CF ASL was not explained by pH-independent changes in HCO3-concentration, altered glycosylation, additional pH-induced disulfide bond formation, increased percentage of nonvolatile material, or increased sulfation. Treating acidic ASL with hypertonic saline or heparin largely reversed the increased viscosity, suggesting that acidic pH influences mucin electrostatic interactions. These findings link loss of cystic fibrosis transmembrane conductance regulator-dependent alkalinization to abnormal CF ASL. In addition, we found that increasing Ca2+ concentrations elevated ASL viscosity, in part, independently of pH. The results suggest that increasing pH, reducing Ca2+ concentration, and/or altering electrostatic interactions in ASL might benefit early CF.
AB - Cystic fibrosis (CF) disrupts respiratory host defenses, allowing bacterial infection, inflammation, and mucus accumulation to progressively destroy the lungs. Our previous studies revealed that mucus with abnormal behavior impaired mucociliary transport in newborn CF piglets prior to the onset of secondary manifestations. To further investigate mucus abnormalities, here we studied airway surface liquid (ASL) collected from newborn piglets and ASL on cultured airway epithelia. Fluorescence recovery after photobleaching revealed that the viscosity of CF ASL was increased relative to that of non-CF ASL. CF ASL had a reduced pH, which was necessary and sufficient for genotype-dependent viscosity differences. The increased viscosity of CF ASL was not explained by pH-independent changes in HCO3-concentration, altered glycosylation, additional pH-induced disulfide bond formation, increased percentage of nonvolatile material, or increased sulfation. Treating acidic ASL with hypertonic saline or heparin largely reversed the increased viscosity, suggesting that acidic pH influences mucin electrostatic interactions. These findings link loss of cystic fibrosis transmembrane conductance regulator-dependent alkalinization to abnormal CF ASL. In addition, we found that increasing Ca2+ concentrations elevated ASL viscosity, in part, independently of pH. The results suggest that increasing pH, reducing Ca2+ concentration, and/or altering electrostatic interactions in ASL might benefit early CF.
UR - http://www.scopus.com/inward/record.url?scp=84959908589&partnerID=8YFLogxK
U2 - 10.1172/JCI83922
DO - 10.1172/JCI83922
M3 - Article
C2 - 26808501
AN - SCOPUS:84959908589
SN - 0021-9738
VL - 126
SP - 879
EP - 891
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 3
ER -